Brief: Calliditas Therapeutics Q4 Revenues At SEK 429.0 Million

Calliditas Therapeutics AB

23/02/2023 07:41

Feb 23 (Reuters) - Calliditas Therapeutics AB
 CALTX.ST :
    * YEAR-END REPORT, 2022
    * Q4 TOTAL Q4 REVENUES WERE SEK 429.0 MILLION
    * FOR 2023, CALLIDITAS EXPECTS ACCELERATED REVENUE GROWTH IN
U.S.
WHERE NET SALES FROM TARPEYO ARE ESTIMATED TO BE USD 120-150
MILLION FOR YEAR ENDING DECEMBER 31, 2023.

Source text for Eikon:  ID:nWkr4VzV54 
Further company coverage:  CALTX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))